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ABSTRACT: Introduction: The mortality rate among tuberculosis patients (TB fatality) has been attributed to 
irregular chemotherapy, delay in diagnosis, multidrug resistance, and HIV coinfection. Objective: To analyze TB 
fatality rates by sex, clinical presentation and HIV coinfection in Campinas, São Paulo, Brazil. Methods: Cohorts 
of  residents in the city of  Campinas who either died during treatment for tuberculosis or had the disease 
confirmed after death were divided into three intervals: 2001–2003, 2004–2006, and 2007–2009. Data were 
obtained from the database of  the Tuberculosis Surveillance System of  the University of  Campinas, and 
notifications were gathered through TB-WEB Health São Paulo Secretary. Statistical significance was 
determined using a chi-square test, considering p < 0.05. Results: Between 2001 and 2009, 3,416 TB patients 
were diagnosed: 2,827 (82.8%) were new TB cases and 589 (17.2%) were retreatments. Between the first and 
second triennium, the number of  new patients decreased by 18%, and 23% among retreatments. Between the 
second and third intervals, the reduction was 5% and 21%, respectively. General case fatality rate declined 
from 11.4% to 9.9% across intervals, and was most significant among patients that had previously abandoned 
treatment (17.3% to 5.1%). Fatality rates among patients coinfected with TB-AIDS were 2–3 times that of  
patients not infected with TB-AIDS throughout the intervals. Fatality between the first and third triennium 
among TB-AIDS co-infected patients declined (24.8% to 19.5%), while increasing slightly among non-AIDS TB 
patients (7.3% to 8%) during this period. Conclusion: Though mortality among TB-AIDS patients declined from 
2001–2009, rates among non-AIDS TB remained stagnant. Improved TB diagnosis and treatment is needed to 
further decrease TB mortality in Campinas.  
Keywords: Tuberculosis. AIDS. Case fatality rate. Comorbidity. Treatment. Mortality.
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INTRODUCTION
Brazil still remains on the World Health Organization’s list of  22 high-burden tubercu-
losis (TB) countries, although the country has successfully met the Stop TB Partnership 
target of  a 50% reduction in the mortality rate by 20151.
The emergence of  the HIV epidemic in the 1980s led to global changes in the epidemiologic 
trend of  tuberculosis morbidity and mortality, reversing decades of  declining rates. Prior to 
the HIV epidemic, TB surveillance and control programs were shortchanged as resources 
were shifted from the TB program to other programs2, thus setting the stage for a reemerging 
epidemic in the late 1980s3,4. The advent of  antiretroviral treatment (ART) programs in the 
mid 1990s helped to decrease TB mortality among TB-AIDS patients in Brazil5, particularly 
because Brazil took the bold step of  paying for ART for patients in need6. Furthermore, the 
expansion of  the WHO’s DOTS strategy significantly impacted TB mortality worldwide7.
In Campinas, a large industrial city in the state of  São Paulo, the richest in the country, 
a reduction in case fatality rates was observed between 1993 to 2000 from 18.1% to 13.5%. 
This reduction was determined to be related to the introduction of  ART5. The Campinas 
health care system is well organized, and at present, primary care is offered at 65 clinics. 
As  in all of  Brazil, TB and HIV/AIDS laboratory exams and treatment are free. Treatment of  
RESUMO: Introdução: A letalidade por tuberculose tem sido atribuída à quimioterapia irregular, à demora no 
diagnóstico, à multidrogarresistência, à coinfecção com o vírus da imunodeficiência humana (HIV). Objetivo: Analisar 
letalidade por tuberculose segundo sexo, apresentação clínica, presença da coinfecção pelo HIV, em Campinas, São 
Paulo, Brasil. Metodologia: Foram verificadas coortes de residentes em Campinas que morreram durante tratamento 
para tuberculose e aqueles notificados após óbito, agrupados em três intervalos: 2001–2003, 2004–2006 e 2007–2009. 
As informações foram obtidas no Banco de Dados para Vigilância da Tuberculose da Universidade Estadual de 
Campinas (UNICAMP), com captação das notificações no Sistema de Notificação e Acompanhamento de Casos 
de Tuberculose da Secretaria Estadual de Saúde de São Paulo. A significância estatística foi verificada pelo teste 
χ2 considerando p < 0,05. Resultados: Entre 2001 e 2009, foram diagnosticados 3.416 pacientes com tuberculose: 
2.827 (82,8%) sem tratamento anterior e 589 (17,2%) com retratamentos. Entre o primeiro e o segundo triênio, o 
número de pacientes novos diminuiu 18% sem tratamento anterior e 23% entre retratamentos. Entre o segundo 
e o terceiro intervalo, a redução foi de 5 e 21%, respectivamente. A letalidade geral declinou de 11,4 para 9,9%, 
diferença mais significante entre os que haviam abandonado tratamento anteriormente (17,3 para 5,1%). A letalidade 
entre pacientes com coinfecção tuberculose-síndrome da imunodeficiência adquirida (Aids) foi 2–3 vezes maior 
que entre tuberculose sem aids durante todo o período estudado. A letalidade entre o primeiro e o terceiro triênio 
declinou no grupo com tuberculose-aids (24,8 para 19,5%), enquanto teve ligeiro aumento entre tuberculose sem 
aids (7,3 para 8%). Conclusão: Embora a mortalidade entre pacientes com tuberculose-aids tenha diminuído de 
2001–2009, as taxas no grupo tuberculose sem aids permaneceram estagnadas. Melhorias no diagnóstico e no 
tratamento são necessárias para a redução da mortalidade entre pacientes com tuberculose em Campinas.
Palavras-chave: Tuberculose. Aids. Letalidade. Comorbidade. Tratamento. Mortalidade.
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drug sensitive pulmonary tuberculosis with standard anti-tuberculosis drugs is highly effica-
cious, though some patients receiving these drugs still die. We set out to determine mortality 
trends in Campinas, specifically, to describe TB case fatality rates by sex, clinical presenta-
tion and presence of  HIV co-infection in the period of  2001 to 2009, stratified by triennium.
METHODS
TB morbidity and mortality data were abstracted from local registries for residents of  
Campinas city (the State of  São Paulo, Brazil) from January 1, 2001 through December 31, 
2009. The analysis included patients that died during treatment and those that were diag-
nosed after death. Prisoners and all patients with non-tuberculosis mycobacterium were 
excluded from the study.
Pulmonary TB cases were defined by a sputum positive smear and/or culture for myco-
bacteria (BK), or suggestive radiology images with respiratory complaints. Extra-pulmonary 
TB was defined by a positive smear/culture for BK in any secretion, liquid or tissue sample, 
from radiology, histology or laboratory analysis.
Since 1993, a TB Surveillance Data Bank has been kept by the State University of  
Campinas. Data were retrieved from the National Notification System (SINAN) adminis-
tered by the Health Ministry through 2006, and since 2007 from the TB-WEB, run by the 
São Paulo Health Secretary.
The TB Surveillance Data Bank includes all variables registered in the case notification 
form, including registration date, smear and culture results, radiology and laboratory anal-
ysis, date treatment began, anti-tuberculosis drugs and treatment outcomes. TB-AIDS was 
defined by the assistant doctor and registered in the comorbidity item of  the notification form.
The main demographic variables included in this analysis were sex, age, and primary 
health unit that reported the case. Health variables included type of  entrance in the noti-
fication system — new case or history of  previous treatment (relapse, dropout or failure), 
clinical presentation (pulmonary and extra-pulmonary), laboratory exams (smear, culture, 
HIV), presence of  other diseases (AIDS, diabetes, alcoholism, etc.), and treatment outcome 
(cure, county transfer, dropout, death, failure). Thus death data registered in SINAN or 
TB-WEB underwent confirmation and eventual correction using SIM. The later was used 
to verify under-notification.
Data tabulation of  new cases, relapse, dropout and failure among cases and deaths, cal-
culation of  case-fatality rates by period, and stratification by sex, period and clinical form 
was performed using Epi Info 6.04d and Microsoft Excel 2007 for three periods 2001–2003, 
2004–2006 and 2007–2009. Statistical significance among proportions was determined using 
the chi square test (p < 0.05). Trends were analyzed using the chi square test for linear trends 
by Epi Info Statcalc, version 6.04. 
The project was approved by the Ethics Research Committee of  the School of  Medical 
Sciences at the State University of  Campinas. 
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RESULTS
Between 2001 and 2009, 3,416 TB cases were diagnosed. Of  these, 2,827 (82.8%) were 
newly diagnosed TB cases and 589 (17.2%) were retreatment cases. Across the first 3-year 
intervals, new cases diminished 18%, while retreatment cases declined 23%. The decline 
was 5 and 21%, respectively, between the second and third intervals. General case fatality 
rate had a slight but not significant decline from 11.4 to 9.9% between the first and third 
triennium. Prior treatment dropout was the only group where fatality rate diminished sig-
nificantly, from 17.3 to 5.1%. There was a decreasing linear trend for retreatment cases vs 
new cases (p = 0.038), and the same occurred for deaths (p = 0.038) (Table 1).





n % n % n %
Entrance 
New case 1088 81.4 891 82.4 848 84.9 0.087
Relapse 111 8.3 92 8.5 69 6.9 0.336
Previous dropout 133 10.0 95 8.8 79 7.9 0.198
Failure 4 0.3 3 0.3 3 0.3 0.994
Total number of cases 1336 100 1081 100 999 100
Deaths
New case 116 76.3 94 81.0 86 86.9 0.117
Relapse 13 8.6 14 12.1 8 8.1 0.528
Previous dropout 23 15.1 8 6.9 4 4.0 0.007
Failure 0 0 0 0 1 1.0 -
Total number of deaths 152 100 116 100 99 100
Fatality rate
New case 10.7 10.5 10.1 0.929
Relapse 11.7 15.2 11.6 0.701
Previous dropout 17.3 8.4 5.1 0.014
Failure - - 33.3 -
General 11.4 10.7 9.9 0.526
Statcalc linear trend for retreatment patients vs new patients p = 0.038; Statcalc linear trend for retreatment deaths vs 
new patient deaths p = 0.038.
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During the whole study period, 687 (20.1%) patients were notified to have TB-AIDS 
and 2,729 (79.9%) did not have the coinfection (Table 2). Males constituted the vast major-
ity of  cases (68.4%) and deaths (74.1%), both among TB-AIDS and non-AIDS TB patients. 
The case fatality rate was more than double for TB-AIDS patients compared to non-AIDS 
Table 2. Tuberculosis patients with and without AIDS, according to sex, death and fatality rates. 
Campinas, SP, Brazil, 2001 to 2009.
Statcalc linear trend for TB-AIDS male patients vs non-AIDS TB male patients p < 0.0001; Statcalc linear trend for 




n % n % n %
TB-AIDS
Patients (N = 687)
Female 80 25.7 61 29.5 55 32.5
0.269
Male 231 74.3 146 70.5 114 67.5
Total 311 100 207 100 169 100
Deaths (N = 160)
Female 17 22.1 19 38.0 11 33.3
0.134
Male 60 77.9 31 62.0 22 66.7
Total 77 100 50 100 33 100
Fatality rate
Female 21.3 31.1 20.0 0.283
Male 26.0 21.2 19.3 0.318
Total 24.8 24.2 19.5 0.406
non-AIDS TB
Patients (N = 2,729)
Female 348 33.9 285 32.6 251 30.2
0.250
Male 677 66.1 589 67.4 579 69.8
Total 1,025 100 874 100 830 100
Deaths (N = 207)
Female 19 25.3 18 27.3 11 16.7
0.303
Male 56 74.7 48 72.7 55 83.3
Total 75 100 66 100 66 100
Fatality rate
Female 5.5 6.3 4.4 0.615
Male 8.3 8.2 9.5 0.658
Total 7.3 7.6 8.0 0.876
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TB patients in the first (24.8 and 7.3%) and last triennium (19.5 and 8.0%). In the first tri-
ennium, among TB-AIDS patients, male fatality rate was the highest (26%). In the second 
triennium, the highest was among female (31.1%). Non-AIDS TB men had higher fatality 
rates than women in all the trienniums. Male TB-AIDS patients compared to non-AIDS TB 
patients had a decreasing linear trend for cases and deaths (p < 0.001) (Table 2). 
TB-AIDS patients had nearly twice or more than three times the fatality rate of  non-
AIDS TB patients, depending on the clinical form and period (Table 3). In 2001–2003, the 
Table 3. Deaths and fatality rates among tuberculosis patients according to clinical presentation 








TB-AIDS 176 18.9 92 12.5 97 13.5
< 0.001non-AIDS TB 757 81.1 642 87.5 624 86.5
Total 933 100 734 100 721 100
Deaths
TB-AIDS 43 44.8 22 31.0 16 22.9
0.010non-AIDS TB 53 55.2 49 69.0 54 77.1
Total 96 100 71 100 70 100
Fatality rate
TB-AIDS 24.4 23.9 16.5 0.288
non-AIDS TB 7.0 7.6 8.7 0.517
Total 10.3 9.7 9.7 0.892
Extra-pulmonary presentation
Patients
TB-AIDS 51 32.9 39 24.8 33 26.0
0.237non-AIDS TB 104 67.1 118 75.2 94 74.0
Total 155 100 157 100 127 100
Deaths
TB-AIDS 9 45.0 13 56.5 9 56.2
0.708non-AIDS TB 11 55.0 10 43.5 7 43.8
Total 20 100 23 100 16 100
Continue...
Tuberculosis faTaliTy raTes in The ciTy of campinas - são paulo, brazil, from 2001 To 2009
7




n % n % n %
Fatality rate
TB-AIDS 17.6 33.3 27.3 0.225
non-AIDS TB 10.6 8.5 7.5 0.728




TB-AIDS 69 31.5 62 36.7 32 23.0
0.035non-AIDS TB 150 68.5 107 63.3 107 77.0
Total 219 100 169 100 139 100
Deaths
TB-AIDS 22 66.7 12 63.2 8 61.5
0.936non-AIDS TB 11 33.3 7 36.8 5 38.5
Total 33 100 19 100 13 100
Fatality rate
TB-AIDS 31.9 19.4 25.0 0.260
non-AIDS TB 7.3 6.5 4.7 0.684
Total 15.1 11.2 9.4 0.241
 Extra-pulmonary presentation
Patients
TB-AIDS 15 51.7 14 66.7 7 58.3
0.572non-AIDS TB 14 48.3 7 33.3 5 41.7
Total 29 100 21 100 12 100
Deaths
TB-AIDS 3 100 3 100 0 - -
non-AIDS TB 0 - 0 - 0 - -
Total 3 100 3 100 0 - -
Fatality rate
TB-AIDS 20.0 21.4 - 0.417
non-AIDS TB - - - -
Total 10.3 14.3 - 0.404
Statcalc linear trend for new pulmonary TB-AIDS patients vs non-AIDS TB patients p = 0.001; Statcalc linear trend for 
new pulmonary TB-AIDS deaths vs non-AIDS TB deaths p = 0.002.
Table 3. Continuation.
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highest fatality rate was among TB-AIDS retreatment cases with a pulmonary presentation 
(31.9%) (Table 3). From 2004 onwards, the highest fatality rates were among TB-AIDS new 
cases with an extra-pulmonary form (33.3 and 27.3% respectively) (Table 3). 
There were 488 new TB-AIDS patients, 365 (74.8%) of  which had a pulmonary presen-
tation. This proportion was 86.5% among the 2,339 non-AIDS TB patients. Comparing the 
third with the first triennium, these cases decreased by 44.9% among TB-AIDS patients and 
17.6% among non-AIDS TB patients. A decreasing linear trend was observed for new cases 
of  pulmonary TB-AIDS and deaths when compared with non-AIDS TB cases (p = 0.001 
and p = 0.002) (Table 3).
DISCUSSION
In Campinas, the total number of  TB patients has diminished in relation to the annual 
mean of  the first years (1997–2000)5 with Highly Active Antiretroviral Therapy (HAART) 
both among male and female patients with and without HIV.
Fatality rates in the period from 2001 to 2009 were lower than in the period from  1997–2000 
among TB non-AIDS patients5. No consistent differences in the trend of  fatality rates were 
observed among the sexes.
The predominance of  the male sex among both TB non-AIDS and TB-AIDS patients is 
a fact observed by many authors8,9 and also previously described in the city5.
Before HAART in Campinas, the number of  TB-AIDS patients represented 28.7% of  all 
TB cases5. This proportion dropped to 24.6% after HAART was introduced5. In the years 
covered by this study, it gradually decreased to 23.3% (2001–2003), 19.1% (2004–2006) and 
16.9% (2007–2009).  
In consonance with several studies10 performed in Campinas, TB-AIDS cases presented 
much higher fatality rates (19.5 to 24.8%) than TB non-AIDS cases (7.3 to 8.0%). Similar fatal-
ity rates were observed in 2000–2006 in the State of  Espírito Santo, Brazil (28.8% among 
TB-AIDS patients and 5.9% among non-AIDS TB patients)11. In a sample of  2,473 hospital-
ized patients in the city of  São Paulo, Brazil in 2001, fatality rates were similar for TB-AIDS 
cases (24%) but much higher among non-AIDS TB cases (15.1%), which can be explained 
by the severity of  the clinical presentation of  patients that need hospital care, considering 
that disseminated TB that killed 66% of  the patients with this clinical form12. In a cohort 
of  887 pulmonary TB patients followed for two years in a Tanzanian city13, fatality among 
the TB-AIDS cases (29.7% in 471 patients) was similar to that in Campinas, and quite lower 
among non-AIDS TB cases (3.6% in 416 patients). In spite of  this later fatality13, it can be 
argued that important efforts need to be done in Campinas to reduce fatality among pul-
monary TB patients without HIV.
The lack of  significant reduction in the fatality rates of  TB-AIDS in Campinas denotes 
no real improvement in treatment. On the other hand, the reduction in the proportion of  
patients with TB-AIDS represents an advancement in the prevention and control of  AIDS, 
Tuberculosis faTaliTy raTes in The ciTy of campinas - são paulo, brazil, from 2001 To 2009
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since less people become ill with TB-AIDS. In New York City, between 1995 and 2004, the 
fatality rate of  TB-AIDS decreased from 26% to 14%14. In Cambodia, a study of  490 non-
AIDS TB patients and 339 TB-AIDS patients treated in TB clinics, observed a case-fatality rate 
of  37% in 2004 when HAART had not been implemented, and a 18% rate in 2005, when it 
was used along with anti-TB treatment15. In the same years, among non-AIDS TB patients, 
the fatality rate remained at 5%15. As observed by Lawn et al.16, to reduce mortality among 
AIDS patients, early diagnosis and ARV treatment must be improved, because mortality is 
associated with low CD4 cell count, less than 50 cells/µl, and an advanced stage of  the dis-
ease. In Rio de Janeiro, Brazil, the proportion of  AIDS patients with tuberculosis diagnosed 
annually decreased from 24.4% in 1995 to 15.2% in 1998, but from 1995 to 2004, there was 
no further improvement. Pacheco et al.17 pointed out that to reduce TB incidence among 
AIDS patients, earlier HIV/AIDS diagnosis and ART initiation is needed.
Although extra-pulmonary TB is more difficult to diagnose than pulmonary TB, in 
Campinas, their fatality rates were not significantly different among new and retreatment 
cases, and among non-AIDS TB and TB-AIDS cases. Since clinical presentation does not 
contribute to differences in fatality rates, it may be observed that once extra-pulmonary 
presentations are diagnosed, they are adequately treated.
In essence, treating patients with a previous history of  TB might be more difficult than 
treating new cases, because of  immunologic deficiencies among relapse patients, resistance 
to adherence among dropouts, or multidrug resistance among failures. Nevertheless, in 
Campinas, a significant reduction in fatality rates among patients with previous dropout 
(p < 0.014) was observed. This data points to better management of  retreatment patients, 
with a provable improvement in the quality of  management, resulting in higher adherence 
to treatment.
Most conditions related to higher TB incidence and TB fatality are poor living condi-
tions, being homeless, unhealthy lifestyle (smoking and alcoholism)1, all of  which are in 
some degree related to poor schooling18,19. Health Education is an important issue in the 
management of  TB. It has been observed that people that have a general knowledge about 
TB have better care-seeking behavior and understand the need of  daily and prolonged 
treatment20, having higher adherence to treatment. In Rio de Janeiro, in populations living 
in slums, it was observed that when community health workers were engaged in Directly 
Observed Treatment Short-courses (DOTS), the patients adherence to treatment was higher21. 
These professionals are able to communicate with efficiency among poor people, reducing 
social inequalities in health. 
Interrupting treatment during the intensive phase has been associated with increased 
risk of  death22, and it represents lack of  adherence. In Campinas, as in all of  Brazil, DOTS 
is considered to be present when 24 doses are supervised in the first 60 days of  treatment23. 
This lower number of  supervised doses might be a point to be improved in order to reduce 
morbidity and mortality. In Rio de Janeiro, patients’ engagement in DOTS conducted by 
community health workers resulted in higher cure rates and lower fatality, when compared 
to self-administered therapy21. 
OLIVEIRA, H.B. ET AL.
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Some limitations of  this manuscript, with secondary data, include lack of  information 
to track dropouts and transfers. As such, our fatality rates may be underreported. Also, the 
lack of  information from DOTS at an individual level impairs the possibility of  evaluating 
the importance of  this factor. In TB-AIDS cases, the lack of  clinical severity variables, such 
as CD4 cell count, is a barrier in understanding the degree in which it contributes to fatal-
ity rates. 
CONCLUSION
Although the absolute number of  cases, mainly those with a pulmonary presentation and 
with TB-AIDS, decreased in Campinas, non-AIDS TB and TB-AIDS fatality rates have not 
diminished, except for previous dropouts, which remain much higher than in other coun-
tries or cities reported in this paper. Epidemiological surveillance has an important role in 
evaluating the adequate registration of  the compulsory notification form and in monitor-
ing TB cases reported in a municipality.
Considering that TB is curable, and thus deaths from this disease are avoidable, the 
quality of  the diagnosis process — treatment initiation and adequate quality of  treatment, 
including direct supervision according to the terms defined by the WHO and patient fol-
low-up — must be constantly revised in order to decrease fatality rates in Campinas.
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